Sparrow Pharmaceuticals
PORTLAND, OR · CIK 0001786949 · Biotech · Private
Novel targeted therapies for corticosteroid excess disorders
sparrowpharma.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $73M
- 4 Form D · Jul 2025
- 15 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 20
- 2 granted · 18 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2019202020212022202320242025
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $270,000 | |
| Private capital raised | Form D · SEC | $1,075,255 | |
| Private capital raised | Form D · SEC | $10,000,000 | |
| Private capital raised | Form D · SEC | $61,841,225 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1940 | Quotient Ltd | — | $92M |
| 1941 | Myota, Inc. | — | $16M |
| 1942 | AXIOMX INC | — | — |
| 1943 | Sparrow Pharmaceuticals | — | $73M |
| 1944 | Iviva Medical | — | $2.0M |
| 1945 | PanTheryx, Inc. | — | $84M |
| 1946 | Vero Biotech Inc. | — | $84M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Robert JacksDirector · Executive Officer
- David KatzDirector · Executive Officer
- Nanna L?neborgDirector
- Niall O'DonnellDirector
- Jonathan RootDirector
- Zach ScheinerDirector
- Peter ThompsonDirector
- Klaus VeitingerDirector
Patents
- Methods And Compositions For Treating Glucocorticoid Excessapplication
- Methods And Compositions For Treating Glucocorticoid Excessapplication
- Methods And Compositions For Treating Glucocorticoid Excessapplication
- Methods And Compositions For Treating Glucocorticoid Excessapplication
- Methods And Compositions For Treating Glucocorticoid Excessapplication
- Methods And Compositions For Treating Glucocorticoid Excessapplication
- Methods For Administering Corticosteroidsapplication
- Methods And Compositions For Treating Glucocorticoid Excessgranted
- Methods For Administering Corticosteroidsgranted
- Methods And Compositions For Treating Glucocorticoid Excessapplication
- Methods For Administering Corticosteroidsapplication
- Methods And Compositions For Treating HSD-1-MEDIATED Disordersapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.